Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
How a rare drug made from scientists' blood saves babies from botulism - 2Dozens injured in Russia after train crashes, overturns
- 3'Peaky Blinders: The Immortal Man' teaser trailer reveals Cillian Murphy's Tommy Shelby back in action
- 4Irish defence minister's trip to Lebanon cancelled
- 5Manageable Living: Eco-Accommodating Decisions for Regular day to day existence
- Doomed SpaceX Starlink satellite photographed from orbit
- Europe picks companies to help build Argonaut moon lander
- Several injured as man threatens attack on German high-speed train
- 'Stranger Things' Season 5: When does Volume 2 come out? And Volume 3? Everything to know about the remaining episodes before the finale.
- Getting breast implants was a mistake I live with every day. Why I’m sharing my story now, at 70, in pain and afraid.
- Astronomers detect rare 'free floating' exoplanet 10,000 light-years from Earth
- 2 of Earth's rarest lightning phenomena captured simultaneously in once-in-a-lifetime photo
- Well known Travel Booking Locales: What's Your Pick?
- Iran fires one of largest barrages in weeks ahead of Passover
